Clinical Heterogeneity of Acquired Idiopathic Isolated Adrenocorticotropic Hormone Deficiency

Front Endocrinol (Lausanne). 2021 Feb 19:12:578802. doi: 10.3389/fendo.2021.578802. eCollection 2021.

Abstract

Objective: Heterogeneous clinical characteristics are observed in acquired isolated adrenocorticotropic hormone (ACTH) deficiency (IAD); however, its classification remains to be established because of its largely unknown pathophysiology. In IAD, anti-pituitary antibodies have been detected in some patients, although their significance remains unclear. Therefore, this study aimed to classify patients with IAD and to clarify the significance of anti-pituitary antibodies.

Design and methods: We analyzed 46 consecutive patients with IAD. Serum anti-pituitary antibodies were analyzed via immunofluorescence staining using a mouse pituitary tissue. Principal component and cluster analyses were performed to classify IAD patients based on clinical characteristics and autoantibodies.

Results: Immunofluorescence analysis using the sera revealed that 58% of patients showed anti-corticotroph antibodies and 6% of patients showed anti-follicular stellate cell (FSC) antibodies. Principal component analysis demonstrated that three parameters could explain 70% of the patients. Hierarchical cluster analysis showed three clusters: Groups A and B comprised patients who were positive for anti-corticotroph antibodies, and plasma ACTH levels were extremely low. Groups A and B comprised middle-aged or elderly men and middle-aged women, respectively. Group C comprised patients who were positive for the anti-FSC antibody and elderly men; plasma ACTH levels were relatively high.

Conclusions: Patients with IAD were classified into three groups based on clinical characteristics and autoantibodies. The presence of anti-corticotroph antibody suggested severe injury to corticotrophs. This new classification clearly demonstrated the heterogeneity in the pathogenesis of IAD.

Keywords: anti-corticotroph antibody; anti-follicular stellate cell antibody; anti-pituitary antibody; classification; cluster analyses; hypopituitarism; isolated ACTH deficiency; principal component analyses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Insufficiency / blood*
  • Adrenal Insufficiency / diagnosis
  • Adrenal Insufficiency / epidemiology*
  • Adrenocorticotropic Hormone / blood
  • Adrenocorticotropic Hormone / deficiency
  • Adult
  • Aged
  • Animals
  • Autoantibodies / blood*
  • Case-Control Studies
  • Cluster Analysis
  • Endocrine System Diseases / blood
  • Endocrine System Diseases / diagnosis
  • Endocrine System Diseases / epidemiology
  • Female
  • Genetic Diseases, Inborn / blood
  • Genetic Diseases, Inborn / diagnosis
  • Genetic Diseases, Inborn / epidemiology
  • Humans
  • Hypoglycemia / blood
  • Hypoglycemia / diagnosis
  • Hypoglycemia / epidemiology
  • Japan / epidemiology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Middle Aged
  • Principal Component Analysis
  • Retrospective Studies

Substances

  • Autoantibodies
  • Adrenocorticotropic Hormone

Supplementary concepts

  • ACTH Deficiency, Isolated
  • Adrenocorticotropic hormone deficiency